Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Junyue Shen"'
Autor:
Guangchao Gu, Xiaoyan Zhang, Junyue Shen, Shayan Gulidanna, Qiong Gao, Jiang Shao, Bao Liu, Bo Zhang, Yuehong Zheng
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThe objectives of this study were to prospectively 1) explore the characteristics and enhanced patterns of carotid body tumors (CBTs) at color Doppler ultrasound (CDU) and contrast-enhanced ultrasonography (CEUS) qualitatively and quantitati
Externí odkaz:
https://doaj.org/article/178c459cb11c4009adbac40f9560744c
Autor:
Junyue Shen, Dan Yang, Mailin Chen, Leilei Jiang, Xin Dong, Dongming Li, Rong Yu, Huiming Yu, Anhui Shi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundHypofractionated radiotherapy (HypoRT) has been used to pursue an alternative treatment regimen for patients with non-small-cell lung cancer (NSCLC) who are not eligible for stereotactic ablative radiotherapy (SABR), surgery or concurrent c
Externí odkaz:
https://doaj.org/article/2a95c61b210f4983a06427981a5d4fc5
Autor:
Jing You, Shuchai Zhu, Jiancheng Li, Jie Li, Junyue Shen, Yidian Zhao, Xiaomin Li, Lin Jia, Qingshan Li, Jun Yang, Yiqun Wu, Wenbin Shen, Haishan Wu, Xueqin Wu, Xiaomin Wang, Yaqiong Ren, Jun He, Pingping Lin, Guangying Zhu, Anhui Shi
Publikováno v:
International journal of radiation oncology, biology, physics.
The standard dose of definitive concurrent chemoradiotherapy (dCRT) remains 50.4 Gy in patients with esophageal cancer; a higher dose, when applied conventional radiotherapy techniques, increases toxicities without improving survival. We investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf8863e5f25dcb45b26e7c2da13d54f
https://pubmed.ncbi.nlm.nih.gov/36402359
https://pubmed.ncbi.nlm.nih.gov/36402359
Autor:
Yuehong Zheng, Loubin Si, Yu Chen, Gulidanna Shayan, Yue-Wei Wang, Junyue Shen, Bao Liu, Jiang Shao
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 29:295-301
OBJECTIVES Cervical aortic arch with aneurysm formation is considered an extremely rare condition. Here, we summarize our experience in treating 8 patients. We validated extra-anatomic ascending-to-infrarenal abdominal aorta bypass through the retrop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::201e54516ecc754f7c6cf1fb7b973e83
https://doi.org/10.1093/icvts/ivz087
https://doi.org/10.1093/icvts/ivz087
Autor:
Xin Dong, Huiming Yu, Leilei Jiang, Dongming Li, Mailin Chen, Dan Yang, Rong Yu, Junyue Shen, Anhui Shi
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundHypofractionated radiotherapy (HypoRT) has been used to pursue an alternative treatment regimen for patients with non-small-cell lung cancer (NSCLC) who are not eligible for stereotactic ablative radiotherapy (SABR), surgery or concurrent c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1804abd2e55f3e83e602a96cfc78cf9
https://pubmed.ncbi.nlm.nih.gov/34221967
https://pubmed.ncbi.nlm.nih.gov/34221967
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 28:989-991
Thoracic venous aneurysms are rare, with the fusiform superior vena cava being the most commonly reported. Isolated innominate vein aneurysms are extremely rare. Herein, we report the case of a saccular left innominate vein aneurysm with an intralumi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3d64eef9135f1df5494f193fd5bdb4
https://doi.org/10.1093/icvts/ivy324
https://doi.org/10.1093/icvts/ivy324